主动脉瓣修复术较置换术带来更好的1年生存:德国主动脉瓣注册研究结果
基于德国主动脉瓣注册研究2011至2015年8076例主动脉瓣反流患者数据,比较主动脉瓣修复术(2327例,29%)与外科主动脉瓣置换术(5749例,71%)的1年结局。倾向评分加权后,修复组1年生存率97.7% vs 置换组96.4%(log-rank P < .001),Cox回归风险比0.68(95% CI,0.51-0.90;P < .0001),1年无心脏事件生存率修复组85.7% vs 置换组81.7%(log-rank P < .001),再干预率两组均为1.6%(P = .59)。
要点
- 主动脉瓣修复组1年生存率97.7%,高于置换组的96.4%(log-rank P < .001)。
- Cox回归显示修复较置换的1年生存风险比为0.68(95% CI,0.51-0.90;P < .0001)。
- 1年无心脏事件生存率修复组85.7% vs 置换组81.7%(log-rank P < .001),再干预率均为1.6%(P = .59)。
核心结论
- 主动脉瓣修复手术,只要术中可行,与外科主动脉瓣置换相比与显著更好的1年生存和1年无心脏事件生存相关。
研究设计与样本
- 基于德国主动脉瓣注册研究的真实世界数据,纳入2011至2015年期间接受主动脉瓣外科手术的8076例主动脉瓣反流患者(平均年龄59.1 ± 15.0岁;76%为男性;平均STS评分1.3 ± 1.1)。
- 其中2327例(29%)接受主动脉瓣修复,其余5749例(71%)接受外科主动脉瓣置换。
- 采用包含年龄、性别和STS评分的加权倾向评分模型校正修复组与置换组之间的基线差异。
- 主要终点为修复 vs 置换后的1年生存,次要终点为无心脏事件生存和无主动脉瓣再干预。
主要发现
- 1年生存率:修复组97.7%(95% CI,97.0%-98.5%)vs 倾向评分加权置换组96.4%(95% CI,95.9%-96.9%)(log-rank P < .001)。
- Cox回归显示修复 vs 置换对1年生存有显著优势(风险比0.68;95% CI,0.51-0.90;P < .0001),且独立于年龄。
- 1年无心脏事件生存率:修复组85.7%(95% CI,483.8%-87.7%)vs 置换组81.7%(95% CI,80.7%-82.9%)(log-rank P < .001)。
- 主动脉瓣再干预:修复组38例(1.6%)vs 置换组1.6%(P = .59)。
临床怎么用
- 作者认为,主动脉瓣修复手术只要术中可行,与外科主动脉瓣置换相比与显著更好的1年生存和1年无心脏事件生存相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aortic valve (AV) repair is an evolving surgical strategy in the treatment of nonelderly adults with aortic regurgitation. We aimed to determine the 1-year outcome after AV repair vs surgical AV replacement (sAVR) using real-world data from the German Aortic Valve Registry. METHODS: A total of 8076 aortic regurgitation patients (mean age, 59.1 ± 15.0 years; 76% men; mean The Society of Thoracic Surgeons score, 1.3 ± 1.1), who underwent AV surgical procedures between 2011 and 2015, were identified from German Aortic Valve Registry. The AV was repaired in 2327 patients (29%), and the remaining 5749 patients (71%) underwent sAVR. A weighted propensity score model, including the variables of age, sex, and The Society of Thoracic Surgeons score, was used to correct for baseline differences between AV repair and sAVR cohorts. The primary end point was 1-year survival after AV repair vs sAVR. Secondary end points were freedom from cardiac events and AV reinterventions. RESULTS: Survival at 1 year was 97.7% (95% CI, 97.0%-98.5%) in the AV repair cohort vs 96.4% (95% CI, 95.9%-96.9%) in the propensity score-weighted sAVR cohort (log-rank P < .001). Cox regression revealed a significant advantage of AV repair vs sAVR (hazard ratio, 0.68; 95% CI, 0.51-0.90; P < .0001) on 1-year survival, which was independent of age. Cardiac event-free survival at 1 year was 85.7% (95% CI, 483.8%-87.7%) in the AV repair group vs 81.7% (95% CI, 80.7%-82.9%) in the sAVR group (log-rank P < .001). AV reintervention was required in 38 AV repair patients (1.6%) compared with 1.6% in the sAVR cohort (P = .59). CONCLUSIONS: AV repair surgery, whenever intraoperatively feasible, is associated with a significantly better 1-year survival and 1-year cardiac event-free survival compared with sAVR.
引用
- Girdauskas E, Balaban Ü, Herrmann E, et al. Aortic Valve Repair Results in Better 1-Year Survival Than Replacement: Results From German Aortic Valve Registry. Ann Thorac Surg. 2023. PMID: 37625612. doi:10.1016/j.athoracsur.2023.07.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。